Figures computed from official regulatory filings — .
Analysttarget 26 USD (+1744%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 2.66% · institutions 56.35% · short 2.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Alzamend Neuro, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. The company's pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
Market information source · Oct 5, 2026
SEC company identity · Oct 5, 2026
Open-market timeline · full history
131 buys37 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| AULT MILTON C IIItrack record | Buy | $108.9K | conv 76 |
| SEC |
| AULT MILTON C IIItrack record | Sell | $3.1K | SEC |
| AULT MILTON C IIItrack record | Buy | $2.1K | conv 38 | SEC |
| AULT MILTON C IIItrack record | Buy | $108.9K | conv 76Unusual size | SEC |
| AULT MILTON C IIItrack record | Buy | $2.1K | conv 38 | SEC |
| DIGITAL POWER CORPtrack record | AwardD (derivative) | $7.5M | SEC |
| AULT MILTON C IIItrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Oram Jeffrey | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Jackman Stephan | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| GUSTAFSON MARKtrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| DIGITAL POWER CORPtrack record | AwardD (derivative) | $7.5M | SEC |
| Horne William Btrack record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Katzoff David J | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Nisser Henry Carl | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| AULT MILTON C IIItrack record | Sell | $3.8K | SEC |
| Horne William Btrack record | Sell | $7.1K | SEC |
| McGrath Lynne Fahey | Sell | $68.7 | SEC |
| AULT MILTON C IIItrack record | Other | $143.2K | SEC |
| AULT MILTON C IIItrack record | Sell | $47.3K | SEC |
| AULT MILTON C IIItrack record | OtherD (derivative) | $143.2K | SEC |
| AULT MILTON C IIItrack record | Sell | $247.4K | Unusual size | SEC |
| AULT MILTON C IIItrack record | OtherD (derivative) | $232K | SEC |
| AULT MILTON C IIItrack record | Other | $232K | SEC |
| AULT MILTON C IIItrack record | Sell | $201K | SEC |
| AULT MILTON C IIItrack record | Sell | $142.9K | SEC |